Qiagen has a total of 4641 patents globally, out of which 2379 have been granted. Of these 4641 patents, more than 40% patents are active. The United States of America is where Qiagen has filed the maximum number of patents, followed by Europe and Germany. Parallelly, Germany seems to be the main focused R&D centre and also is the origin country of Qiagen.
Qiagen was founded in 1984 by Metin Colpan. Qiagen provides sample and assay technologies. The Company offers such technologies for molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, as well as applied testing customers for purposes such as forensics, animal and food testing, and pharmaceutical process control. As of October 2022, Qiagen has a market cap of $9.56 Billion.
Do read about some of the most popular patents of Qiagen which have been covered by us in this article and also you can find Qiagen patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Qiagen patent portfolio.
How many patents do the Founder and CEO of Qiagen have?
The Founder Metin Colpan has 116 patents, and the CEO Thierry Bernard has 205 patents.
How many patents does Qiagen have?
Qiagen has a total of 4641 patents globally. These patents belong to 1182 unique patent families. Out of 4643 patents, 1883 patents are active.
How Many Patents did Qiagen File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Qiagen Applications Filed | Qiagen Patents Granted |
| 2011 | 304 | 93 |
| 2012 | 277 | 146 |
| 2013 | 280 | 147 |
| 2014 | 160 | 157 |
| 2015 | 182 | 187 |
| 2016 | 240 | 173 |
| 2017 | 100 | 189 |
| 2018 | 77 | 184 |
| 2019 | 106 | 149 |
| 2020 | 87 | 135 |
| 2021 | 37 | 103 |
| 2022 | 13 | 55 |
How many Qiagen patents are Alive/Dead?
Worldwide Patents
How Many Patents did Qiagen File in Different Countries?
Countries in which Qiagen Filed Patents
| Country | Patents |
| United States Of America | 930 |
| Europe | 789 |
| Germany | 537 |
| Japan | 420 |
| Australia | 281 |
| China | 261 |
| Canada | 164 |
| Austria | 111 |
| Spain | 98 |
| Korea (South) | 56 |
| Denmark | 55 |
| United Kingdom | 55 |
| India | 53 |
| Singapore | 44 |
| Brazil | 41 |
| Hong Kong (S.A.R.) | 26 |
| Israel | 22 |
| Russia | 20 |
| Portugal | 16 |
| Taiwan | 14 |
| South Africa | 14 |
| Mexico | 12 |
| Norway | 11 |
| Turkey | 9 |
| Poland | 8 |
| Hungary | 8 |
| Slovenia | 5 |
| New Zealand | 4 |
| Lithuania | 3 |
| Cyprus | 3 |
| Slovakia | 2 |
| Czech Republic | 2 |
| Switzerland | 2 |
| France | 1 |
| Chile | 1 |
| Iceland | 1 |
| Eurasia | 1 |
| Indonesia | 1 |
Where are Research Centers of Qiagen Patents Located?
10 Best Qiagen Patents
US6670461B1 is the most popular patent in the Qiagen portfolio. It has received 1806 citations so far from companies like Isis Pharmaceuticals, Sankyo Company, and Amgen.
Below is the list of 10 most cited patents of Qiagen:
| Publication Number | Citation Count |
| US6670461B1 | 1806 |
| US6794499B2 | 1704 |
| US7034133B2 | 1256 |
| US6770748B2 | 1159 |
| US6339068B1 | 1030 |
| US6828100B1 | 751 |
| US7084125B2 | 708 |
| US7572582B2 | 431 |
| US7060809B2 | 423 |
| US20040219565A1 | 320 |
Which Companies are using Qiagen Patents to Advance their Research?
If patents or patents from a particular technology area of a company receive a lot of citations, it implies that the technology is being followed and incrementally innovated by the citing companies. It also indicates that citing companies are working on similar and closely related technologies.
The top citing companies in the Qiagen patent portfolio are Life Technologies, Roche Molecular Systems and Becton Dickinson.
List of the top forward citing Companies –
| Company | Number of Patents |
| Life Technologies | 20 |
| Roche Molecular Systems | 12 |
| Becton Dickinson | 10 |
| U.S. Department of Health and Human Services | 10 |
| Applied Bio systems Llc | 10 |
| Bio-Rad Laboratories | 9 |
| Samsung Electronics | 8 |
| Ibis Biosciences Inc | 7 |
| Global Life Sciences Solutions | 7 |
| Ionis Pharmaceuticals | 7 |
Count of 102 and 103 Type Rejections based on Qiagen Patents
Top Qiagen Patents used in Rejecting Most Patent Applications
| Patent Number | Count of Rejected Applications |
| US20060176167A1 | 18 |
| US6870165B2 | 15 |
| US8192937B2 | 12 |
| US6617137B2 | 10 |
| US20080117029A1 | 10 |
| US8932542B2 | 9 |
| US20060105372A1 | 9 |
| US20100086990A1 | 8 |
| US6864100B1 | 7 |
| US6361940B1 | 7 |
| US10458998B2 | 7 |
| US20040219565A1 | 7 |
| US20050053942A1 | 7 |
| US20030152927A1 | 6 |
| US7060809B2 | 6 |
What Percentage of Qiagen US Patent Applications were Granted?
Qiagen (Excluding its subsidiaries) has filed 419 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 261 have been granted leading to a grant rate of 66.41%.
Below are the key stats of Qiagen patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Qiagen?
| Law Firm | Total Applications | Success Rate |
| Seed IP | 82 | 66.67% |
| Fanelli Haag | 69 | 60.87% |
| Mcbee Moore & Vanik | 65 | 70.77% |
| Ballard Spahr | 59 | 60.34% |
| Rankin Hill & Clark | 24 | 55.00% |
| Leon R Yankwich | 19 | 57.89% |
| Sterne Kessler Goldstein & Fox | 11 | 100.00% |
| Seyfarth Shaw | 9 | 77.78% |
| Mcdonnell Boehnen Hulbert & Berghoff | 8 | 100.00% |
| Clark & Elbing | 7 | 100.00% |